Research & Education

Approximately one in every five adults1 have sleep-disordered breathing (SDB). An expanding body of scientific evidence clearly indicates that SDB has a profound negative impact on public health. Through its strong partnership with the global medical community, ResMed is committed to: -increasing awareness of the dangers of untreated SDB -supporting ongoing research into the correlation of SDB with other health risks -finding effective clinical solutions to improve the health and lives of SDB patients